Page last updated: 2024-10-25

deferoxamine and Acute Lymphoid Leukemia

deferoxamine has been researched along with Acute Lymphoid Leukemia in 2 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dächert, J1
Schoeneberger, H1
Rohde, K1
Fulda, S1
Haq, RU1
Wereley, JP1
Chitambar, CR1

Other Studies

2 other studies available for deferoxamine and Acute Lymphoid Leukemia

ArticleYear
RSL3 and Erastin differentially regulate redox signaling to promote Smac mimetic-induced cell death.
    Oncotarget, 2016, Sep-27, Volume: 7, Issue:39

    Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Apoptosis Regulatory Proteins; Carbolines; Cell Death; D

2016
Induction of apoptosis by iron deprivation in human leukemic CCRF-CEM cells.
    Experimental hematology, 1995, Volume: 23, Issue:5

    Topics: Apoptosis; Chromatin; Deferoxamine; Ferric Compounds; Gallium; Humans; Insulin; Iron; Neoplastic Ste

1995